Mentholatum (China) Pharmaceuticals Co., Ltd.
FDA inspection history in Zhongshan, China, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Zhongshan, China.
Cited most
Across all Mentholatum (China) Pharmaceuticals Co. observations on file
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.192Production record review1
The complete Mentholatum (China) Pharmaceuticals Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Zhongshan, China
One Form 483 · 2019 · 2 observations
Latest: Form 483, Jun 21, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-06-21 | 483 Form 483 | Zhongshan, China | 2 | $99 |
Investigators on these documents
FEI number 3000188423 · most recent document Jun 21, 2019
About Mentholatum (China) Pharmaceuticals Co., Ltd.
How many FDA Form 483s has Mentholatum (China) Pharmaceuticals Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Mentholatum (China) Pharmaceuticals Co., Ltd.; the most recent is dated Jun 21, 2019.
When was Mentholatum (China) Pharmaceuticals Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Mentholatum (China) Pharmaceuticals Co., Ltd. is a Form 483 dated Jun 21, 2019, for the site in Zhongshan, China.
What did FDA cite at Mentholatum (China) Pharmaceuticals Co., Ltd.?
The regulations cited most in the observations on file for Mentholatum (China) Pharmaceuticals Co., Ltd. are 21 CFR 211.160(b) (General requirements), 1 time; 21 CFR 211.192 (Production record review), 1 time.